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Fetal proteins appear in the adult in beth malignant and nonmalignant 
conditions. Their presence has been thought to indicate a state of altered 
regulation  or  differentiation,  possibly  related  to  the  "phasing" (1)  of  specific  gene 
products.  Where normal constraints  upon growth are altered,  the presence of 
embryonic or fetal  components may be anticipated.  Thus, fetal  antigens have 
been  found  in  the  bone  marrow cells  of  patients  with  erythroid  hyperplasia,  and 
pernicious  anemia (2),  as well as explants of human skin (3) maintained in 
culture  for  3 wk or  more. 
A better  defined and more readily  manipulated model in which to observe 
possible  adaptive changes to altered  growth is  a cell  culture  system. Lympho- 
blastoid  lines  established  from  normal adults  have a unique  capacity  to  grow in 
suspension, to maintain some differentiated  characteristics,  and to remain 
diploid.  This study reports  the presence of  fetal  components on the surface  of 
lymphocytes established  in  long-term culture  from healthy adults. 
Materials and Methods 
Rabbits were immunized with perchloric  acid extracts  of  human fetuses  that had had viscera, 
brain, and spinal cord removed (4).  The antisera were absorbed sequentially  with acetone-dried 
powders of  normal adult liver,  spleen, muscle, brain, and pooled sera.  Further absorption with 
fetal calf  serum did not change the immunofluorescence results.  The absorbed antisera were 
evaluated  by indirect  immunofluorescence with  frozen  sections  or  cell  suspensions of  normal adult 
tissues  and with frozen  sections  of  fetal  tissues.  Significant  reactivity  was not  detected  with adult 
tissues but widespread reactivity  remained  against fetal tissues.  Thus "fetal  antigens"  are 
operationally  defined  by  reactivity  with  these absorbed  antisera.  Similarly  prepared  antisera  have 
been  extensively  evaluated in  earlier  reports  (2-4).  All  cell  lines  were grown in  suspension  culture 
in  RPMI-1640 medium supplemented with 10% heat-inactivated  fetal  calf  serum. With the excep- 
tion  of  MOLT  (5)  and Daudi (6) all  lines  were established  from healthy adult humans. Cultured 
cells  and fresh peripheral blood lymphocytes (PBL) prepared by the Ficoll-Hypaque  method (7) 
were examined by indirect membrane  imrnunofiuorescence  with commercial goat antirabbit 
immunoglobulin  sera (Cappel  Laboratories, Inc., Downingtown,  Pa.), using the microscopic 
system of  Lewis and co-workers (2-4).  In some experiments, adherent cells  were removed by the 
method of Greaves and Brown (8).  For electron microscopy, IgG fractions  from the absorbed 
antisera  were  prepared  by  precipitation  with  50% saturated ammonium sulfate  followed  by  DEAE- 
cellulose chromatography  (9) and then conjugated  with peroxidase  (10). Washed  cells  were 
incubated with the antisera  unfixed or  after  a 15  min fixation  (1.25% buffered  paraformaldehyde) 
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(11).  They were pelleted,  postfixed in buffered osmium, dehydrated, embedded in Spur~s resin, 
and examined with a Philips EM  301 microscope  (Philips  Electronic Instruments,  Inc.,  Mount 
Vernon, N. Y.),  initially  without density enhancement, and for  photography,  after  staining with 
uranyl acetate and lead citrate.  Controls for endogenous or absorbed peroxidase were negative. 
The isotopic  antiglobulin assay was performed according to  Sparks et  al. (12)  with slight  modifica- 
tions. Results are expressed  as an absorption  ratio (counts per minute  of cells and rabbit 
antiserum plus 1251-goat  antirabbit globulin divided by counts per minute of cells  plus normal 
rabbit serum plus 12~I-goat  antirabbit  globulin). 
Results 
The results  shown in Table I indicate  that all of the culturod B-cell  lines 
express fetal  antigens on their  plasma membranes. These inununofluorescence 
data  were confirmed by  the isotopic  antiglobnlin  assay  on  the Mo line,  giving  an 
absorption  ratio  of  2.1 _ 0.4  SD. Further evidence for  the specificity  of  the mem- 
brane reaction  is  demonstrated by  the electron  micrographs (Fig.  1).  Both direct 
and indirect  reactions  show peroxidase staining  at the cell  surface.  The direct 
reaction  was specifically  blocked by unconjugated antisera  but not by normal 
rabbit  sera. 
The MOLT  line,  derived  from a patient  with acute lymphocytic leukemia and 
originally  expressing T-cell  characteristics  (5),  gave a negligible  reaction.  Thy- 
mocytes from two  human thymuses also  had low  reactivity  (<5%). In  contrast,  a 
high  percentage of  cells  from subjects  with chronic  lymphocytic leukemia (CLL) 
reacted with the antisera.  Thus all of the reactive  lymphocytes are B cell  in 
type. 
A small percentage of  fresh  normal PBL showed a positive  fluorescent  reac- 
tion  (Table I). In three experiments the anti-9-wk serum was absorbed with an 
equal volume of  packed cultured  cells.  Reactivity  of  two other  lines  was reduced 
to 20% and that of  fresh  PBL to 7 _+ 2% with greatly  weakened intensity.  The 
reverse experiment with two absorptions with equal volumes of packed PBL 
from four  pooled donors decreased the number of  reacting  PBL from 14 _+ 6% to  7 
_+  4% (no.  of  subjects  tested  (N) = 5),  but  failed  to  alter  the  reactivity  of  the Ce or 
Mo lines.  In several  experiments reactivity  with the antifetal  sera could  be de- 
creased by prior  removal of adherent cells  from the PBL populations by two 
passes through a nylon wool column. The degree of depletion,  however, was 
variable and always less  than that of  immunoglobulin-bearing cells.  In a few 
cases  no depletion  was noted. 
Cultured lymphoblasts were tested  with  antisera  made against  fetal  tissues  of 
ages varying from 9 to 17 wk, but only those  against the earlier  tissues  were 
strongly reactive. This transient age-specific  expression of fetal antigens is 
consistent  with earlier  studies  with these  reagents (2-4). 
Discussion 
It has been claimed that most lymphoblastoid lines are infected with Epstein- 
Barr virus or possess its genome (13); thus, it is possible that these fetal antigens 
reflect viral products. Their presence on leukemic (CLL) lymphocytes  and on the 
Daudi line is consistent with the assertion by Huebner et al. (14) that "virogene" 
products may be expressed prenatally and reappear in adult neoplasia. Thus in 
long-term culture a  "virogene/oncogene" product may be associated with the SULLIVAN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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Cultured lymphoblasts 
Immunofluorescence % of cells staining* 
9 wk  10 wk  10 wk$ 
B-cell lines 
Ce  62  74  58 
JC  -  59  - 
PH  14  54  - 
ESB  75  -  48 
Mo  46  -  44 
Daudi  -  79  84 
T-cen line 
MOLT  16  6  7 
Peripheral blood lymphocytos 
Normals [mean ±  SD (N)]  20 ±  8 (8)  21 ±  9  (13)  26 ±  10 (8) 
Chronic lymphocytic leukemia  -  66 +  10 (3) 
* Percent of cells showing specific membrane immunofluorescence to rabbit polyvalent antifetal sera used at dilutions of 1:4 or 1:5. 
$ Age of fetus extracted for antigen preparation. 
adaptive  response  to  culture and  the  reappearance of developmental-phase 
antigens. 
The role of fetal antigens in the overall cell economy is unknown although 
some functions have been suggested (15, 16). We have shown that those de- 
scribed here vary their expression during the cell cycle with a minimum in the S 
phase (17). The periodic expression of fetal antigens on cycling cells leads us to 
consider whether normal cells recapitulate their ontogeny as they pass through 
the cell cycle. 
The absorption experiments suggest that a  subpopulation of normal adult 
PBL may show antigens related to those detected on cultured B lymphoblasts by 
these antifetal sera. The experiments involving removal of adherent cells on 
nylon wool do not clearly distinguish the reactive cells as either B or T, but 
suggest rather that they may be represented on subpopulations of  both adherent 
and nonadherent cells.  Thus on the one hand these antigens could represent 
developmental surface markers expressed on immature lymphocyte subpopula- 
tions. Their absence from most adult tissues and from the majority of T cells 
argues against reactivity with a public specificity of the usual serologically de- 
fined HLA histocompatibility antigens. However, by analogy with the murine 
embryonic T/t antigens (18), they could represent an embryonic analog of the 
adult histocompatibility complex. On the other hand these fetal antigens may 
represent a lymphoid cell alloantigen system similar if not the same as that de- 
scribed for human B cells (19, 20). The Ia alloantigens of the mouse distribute 
among lymphocyte subpopulations in a manner similar to these fetal antigens 
(21). Moreover, Ia antigens are in negligible concentration on adult liver, brain, 
and muscle-the major tissues used to absorb the antifetal sera used in this 
study. 
Reports  of fetal  antigen  expression in  non-neoplastic tissues  temporarily 
removed from the usual growth constraints (17), and the present observation of 
their appearance on normal-derived  cells in culture suggest that there may exist 
a  potentially reversible phenotypic "crossroads" state  intermediate between 
normality and malignancy. This metastable state may be beth cell-cycle  depend- 1560  SULLIVAN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
FIG.  1.  Immunoelectron microscopic  localization of fetal antigens and specific immune 
block. (A) Cells incubated with IgG fraction of antisera to 12-wk-old fetus followed by goat 
antirabbit IgG-peroxidase  conjugate (indirect). Arrows indicate the electron-dense enzy- 
matic product associated  with the plasma membrane. ×  75,000. (B) Cells incubated with 
unconjugated IgG fraction of antisera followed by peroxidase conjugate (specific immune 
block). No reaction product present on the plasma membrane, × 102,000. 
ent and highly vulnerable to factors favoring malignant transformation. The 
expression of fetal antigens on marrow cells in pernicious anemia (2), a reversi- 
ble condition associated with arrested maturation and increased fetal hemoglo- 
bin production (22) but not neoplasia, may reflect this phenomenon. The serum 
elevations  of carcinoembryonic antigen in  cirrhosis  of the  liver,  ulcerative 
colitis,  and  heavy cigarette smoking  (23), all  of which are  associated with 
increased risk of malignancy, could also originate from cells in this vulnerable 
state. Accordingly, one might expect to find fetal antigens in other premalig- 
nant conditions such as metaplasia and chronic wound sites. If the malignant 
capability becomes established, the cells may still retain their fetal antigens or 
may further revert to the "highly undifferentiated" state, retaining autonomy 
but losing or altering their fetal antigens. This latter situation may apply where 
carcinoembryonic antigen is  no  longer expressed in  highly undifferentiated 
colonic carcinoma (23). 
Summary 
Human B-lymphoblastoid cells established in long-term culture from healthy 
adults carry surface components that are normally found in human fetal tissues 
at about 10 wk of age. These antigens are strongly expressed on neoplastic B 
lymphocytes  but not on thymocytes  or a cultured T-cell line. They are carried by 
a small subpopulation of normal adult peripheral blood lymphocytes as well. 
Received for publication  8 August 1975. 
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